ICON vs Medpace

Auto-generated comparison by BioBM Editorial AI. This page highlights available profile evidence side by side and avoids drawing conclusions from missing fields.

Markdown mirror: /api/markdown/compare/kcrcro/medpace

Category	ICON	Medpace
Listed site	cro	cro
Summary	ICON is a CRO with 8,000 biotech-dedicated professionals offering end-to-end clinical development, consulting, and therapeutic expertise across all development phases.	Full-service CRO with 30+ years of organic growth, offering integrated clinical development services across all phases with wholly-owned central labs, bioanalytical lab, imaging core lab, and Phase I unit.
Services	Phase I Clinical Trials Phase II Clinical Trials Phase III Clinical Trials Phase IV / Post-Marketing Clinical Operations Clinical Trial Services Clinical Imaging Core Lab Central Laboratory Services US FDA Regulatory Strategy EU EMA Regulatory Strategy Regulatory Affairs Medical Writing Cardiovascular & Metabolic Specialty Services CNS Specialty Services Oncology Specialty Services Immunology & Inflammation Services Virology Services Biostatistics & Statistical Programming Data Management & eClinical Japan PMDA Regulatory Strategy China NMPA Regulatory Strategy Translational Research	Clinical Operations Phase I Clinical Trials Phase II Clinical Trials Phase III Clinical Trials Phase IV / Post-Marketing Clinical Trial Services Biostatistics & Statistical Programming Data Management & eClinical Medical Writing Pharmacovigilance & Drug Safety Regulatory Affairs Central Laboratory Services Biomarker Assays Immunogenicity Assays (ADA / NAb) Bioanalysis Clinical Imaging Core Lab Microbiology Services Cardiovascular & Metabolic Specialty Services Oncology Specialty Services Immunology & Inflammation Services Virology Services US FDA Regulatory Strategy EU EMA Regulatory Strategy China NMPA Regulatory Strategy Device & Combination Product Services Japan PMDA Regulatory Strategy CNS Specialty Services Ligand-Binding Bioanalysis (Large Molecule) In Vitro Pharmacology In Vitro ADME / DMPK Preclinical In Vitro Studies Preclinical In Vivo Studies In Vivo Efficacy Models In Vivo PK / PD Studies
Modalities	Biologics (Monoclonal Antibodies) Biologics (Other) Cell Therapy Gene Therapy Vaccine	Small Molecule Biologics (Monoclonal Antibodies) Biologics (Other) Gene Therapy Cell Therapy Vaccine Radiopharmaceutical
Indications	Oncology Neurology Metabolic Cardiovascular Infectious Disease Rare Disease Women's Health	Cardiovascular Dermatology Metabolic Gastroenterology Oncology Immunology Infectious Disease Nephrology Neurology Ophthalmology Respiratory Rare Disease Women's Health
Locations	Data not yet provided.	Central Laboratories, Cincinnati, Ohio, United States Central Laboratory, Cincinnati, Ohio, United States Headquarters, Cincinnati, OH, USA Dallas, Irving, TX, USA Denver, Denver, CO, USA Mexico City, Mexico City, Distrito Federal, Mexico Leuven, Leuven, Flemish Brabant, Belgium Prague, Prague, Prague, Czech Republic Copenhagen, Copenhagen, Copenhagen, Denmark Lyon, Lyon, Auvergne-Rhône-Alpes, France Munich, Munich, Bavaria, Germany Budapest, Budapest, Budapest, Hungary Rehovot, Rehovot, Central, Israel Milan, Milan, Lombardy, Italy London, London, England, United Kingdom Maastricht, Maastricht, Limburg, Netherlands Rotterdam, Rotterdam, South Holland, Netherlands Warsaw, Warsaw, Masovian, Poland Johannesburg, Johannesburg, Gauteng, South Africa Dallas, Dallas, TX, USA Madrid, Madrid, Spain Mexico, Mexico City, Mexico City, Mexico
Certifications	Data not yet provided.	Data not yet provided.
Reviews	Review summary appears after site-level review signal gate opens.	Review summary appears after site-level review signal gate opens.